Development of a prognostic model for breast cancer patients based on intratumoral tumor-infiltrating lymphocytes using machine learning algorithms.
Journal:
Discover oncology
Published Date:
May 14, 2025
Abstract
BACKGROUND: Breast cancer remains a formidable global health challenge, with tumor-infiltrating lymphocytes (TILs) serving as pivotal biomarkers associated with disease progression, therapeutic response, and survival. While research typically focused on stromal TILs (sTILs), we hypothesize that intratumoral TILs (iTILs), which are in direct contact with tumor cells, have a more profound role in the immune-tumor interactions. In light of this, we have developed an iTIL-centric model for breast cancer patient stratification and prognostic prediction.
Authors
Keywords
No keywords available for this article.
